Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Carl E. Clarke »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Carl Counsell < Carl E. Clarke < Carl E. Counsell  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000897 (2002) Katherine H O. Deane [Royaume-Uni] ; Caroline Ellis-Hill ; Diana Jones ; Renata Whurr ; Yoav Ben-Shlomo ; E Diane Playford ; Carl E. ClarkeSystematic review of paramedical therapies for Parkinson's disease.
000E08 (2004) Carl E. Clarke [Royaume-Uni]A "cure" for Parkinson's disease: can neuroprotection be proven with current trial designs?
000E61 (2004) Keith Wheatley ; Carl E. Clarke ; Natalie Ives ; Richard GrayCabergoline versus levodopa monotherapy.
000E85 (2004) Stuart J M. Weatherby [Royaume-Uni] ; Philippa Woolner ; Carl E. ClarkePregnancy in stiff-limb syndrome.
001819 (2006) Olivier Rascol [France] ; David J. Brooks ; Amos D. Korczyn ; Peter P. De Deyn ; Carl E. Clarke ; Anthony E. Lang ; Mona AbdallaDevelopment of dyskinesias in a 5-year trial of ropinirole and L-dopa.
001E65 (2007) Nir Giladi [Israël] ; Babak Boroojerdi ; Amos D. Korczyn ; David J. Burn ; Carl E. Clarke ; Anthony H V. SchapiraRotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole.
002006 (2008) Carl E. Clarke [Royaume-Uni]Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?
002F34 (2010) Claire L. Tomlinson [Royaume-Uni] ; Rebecca Stowe ; Smitaa Patel ; Caroline Rick ; Richard Gray ; Carl E. ClarkeSystematic review of levodopa dose equivalency reporting in Parkinson's disease.
002F98 (2011) Rebecca Stowe [Royaume-Uni] ; Natalie Ives ; Carl E. Clarke ; Kelly Handley ; Alexandra Furmston ; Katherine Deane ; J J Van Hilten ; Keith Wheatley ; Richard GrayMeta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease.
003141 (2011) Carl E. Clarke [Royaume-Uni] ; Smitaa Patel ; Natalie Ives ; Caroline Rick ; Keith Wheatley ; Richard GrayShould treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?
003791 (2012) Laura L. Kilarski [Royaume-Uni] ; Justin P. Pearson ; Victoria Newsway ; Elisa Majounie ; M Duleeka W. Knipe ; Anjum Misbahuddin ; Patrick F. Chinnery ; David J. Burn ; Carl E. Clarke ; Marie-Helene Marion ; Alistair J. Lewthwaite ; David J. Nicholl ; Nicholas W. Wood ; Karen E. Morrison ; Caroline H. Williams-Gray ; Jonathan R. Evans ; Stephen J. Sawcer ; Roger A. Barker ; Mirdhu M. Wickremaratchi ; Yoav Ben-Shlomo ; Nigel M. Williams ; Huw R. MorrisSystematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Carl E. Clarke" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Carl E. Clarke" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Carl E. Clarke
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024